Solid tumor treatments in California

The UCSF Pediatric Solid Tumor Program, located at 1825 4th Street in San Francisco, California, is a world-class institution dedicated to providing specialized evaluation, diagnosis, and care for children, teens, and young adults with solid tumors. Our team of experts handles a range of conditions, from common to rare, including neuroblastoma, hepatoblastoma, bone and soft tissue sarcomas, Wilms' tumors, and other cancers. We also care for patients with relapsed cancers and are known globally for taking on rare and challenging cases. At UCSF, we believe in tailoring cancer therapy to each patient's unique disease, offering high-quality, targeted care that is precise, effective, and compassionate. Our program utilizes advanced diagnostic tools, including genetic tests developed in-house, and provides access to new treatments not widely available elsewhere. As a member of the Oncology Group Phase 1/Pilot Consortium, we are at the forefront of developing new therapies for pediatric cancers.

SMUCLA 4SW Solid Oncology Unit is a leading healthcare institution specializing in the treatment of solid cancers. Located on 15th Street in Santa Monica, California, United States, our dedicated team of oncologists, nurses, and support staff work tirelessly to provide the highest quality care for patients battling cancer. Our state-of-the-art facility offers cutting-edge treatments, personalized care plans, and a compassionate approach to healing. With a focus on research, innovation, and patient-centered care, SMUCLA 4SW Solid Oncology Unit is committed to helping patients fight cancer and live their best lives.

City of Hope Corona is a new, larger multispecialty location, providing unparalleled cancer care closer to home. As a department of City of Hope National Medical Center, this general acute care hospital offers a 32,500-square-foot cancer center with new programs and services for the community. Patients have access to a multidisciplinary team of experts and state-of-the-art services. Specializing in medical oncology, surgery, radiation oncology, and chemotherapy/infusion therapy, City of Hope Corona offers advanced treatments and technologies. The radiation oncology program is accredited by ASTRO, and the facility provides a wide range of specialized services for solid tumors and blood cancers. With nationally recognized experts and ongoing research, City of Hope offers innovative therapies and clinical trials. Conveniently located near major highways, City of Hope Corona provides a positive and healing environment for patients. Expert physicians like Gregory Gilmore, D.O., Mark Hanna, M.D., and Mehdi M. Kebria, M.D., work with patients to develop personalized treatment plans. With a focus on quality of life, City of Hope Corona offers comprehensive care for cancer patients from prevention through survivorship.

City of Hope Thousand Oaks is a leading health institution located at 425 Haaland Drive in Thousand Oaks, California, United States. Our skilled staff specializes in medical oncology, blood disorders, and cancers, offering consultations and second opinions to patients in the local community. From prevention to survivorship, we provide expert care for a wide range of cancers and conditions, utilizing cutting-edge technologies and services. Our nationally recognized experts focus on treating blood cancers and disorders related to blood and tissues, with a special emphasis on ongoing research and clinical trials to provide patients with the most innovative therapies available. Our multidisciplinary team of physicians, researchers, nurse practitioners, and health professionals work together to diagnose and treat a variety of solid tumors, offering the latest advances in chemotherapy, hormonal therapy, targeted therapy, and more.

City of Hope Long Beach Worsham, located at 3747 Worsham Avenue in Long Beach, California, offers unparalleled cancer care and innovative treatments to the local community. With a multidisciplinary team of experts, including physicians, researchers, nurse practitioners, and other health professionals, City of Hope provides cutting-edge therapies for a wide variety of solid tumors and blood cancers. Patients have access to the latest advances in chemotherapy, hormonal therapy, targeted therapy, and more, as well as the opportunity to participate in clinical trials for new treatments. The institution also offers consultations for all types of cancer, as well as for individuals at high risk of developing cancer. City of Hope's signature infusion therapy program provides safe and effective treatment options for various non-oncology conditions. The facility is equipped with state-of-the-art technology and a patient-centered approach to care, ensuring that each individual receives compassionate and personalized treatment.

City of Hope Huntington Beach, located at 19671 Beach Boulevard in Huntington Beach, California, is a leading health institution providing unparalleled cancer care and innovative treatments to the local community and surrounding areas. With a multidisciplinary team of experts including physicians, researchers, nurse practitioners, and other health professionals, City of Hope offers cutting-edge therapies for various cancers and conditions. Patients at City of Hope have access to the latest advancements in chemotherapy, hormonal therapy, biologic therapy, targeted therapy, and other innovative treatments. The institution specializes in treating solid tumors, blood cancers, and disorders related to blood and tissues, with a focus on personalized care and patient-centered approach.

City of Hope Newport Beach is a cutting-edge health institution located in Newport Beach, California. This facility offers personalized cancer therapies, highly specialized physicians, and compassionate care to local communities. The state-of-the-art infusion center provides serene ocean views and comfortable treatment bays, while the patient resource center offers support and information for patients and their families. City of Hope Newport Beach specializes in solid tumors, blood cancers, and various other conditions, offering the latest advances in chemotherapy, immunotherapy, and targeted therapies. The Precision Prevention and Early Detection Program utilizes state-of-the-art technologies to inform individuals of their risk factors. The infusion therapy program caters to a wide variety of non-oncology conditions, providing safe and effective treatments. With a team of expert physicians and researchers, City of Hope Newport Beach is dedicated to providing optimal outcomes for patients across a broad spectrum of diagnoses. This institution is backed by the powerful City of Hope clinical network, ensuring world-class care for Orange County residents. With a focus on patient comfort and personalized care, City of Hope Newport Beach is a beacon of hope for those facing cancer and other health challenges.

Jonathan Jaques Children's Cancer Center, located at 2801 Atlantic Avenue in Long Beach, California, is a renowned health institution specializing in providing quality and compassionate care to children with cancer, sickle cell disease, and other serious blood disorders. The center offers a range of programs to support patients and their families from admission through follow-up treatments. Established in 1983 in honor of Jonathan Jaques, a young cancer patient who inspired the creation of the institute, the center continues to uphold his legacy of generosity and compassion. The Jaques Family remains actively involved in supporting the center, which has grown into a leading institute for pediatric oncology and hematology care in the Long Beach area.

The Proteogenomics Research Institute for Systems Medicine (PRISM) is a non-profit research institute located at 505 Coast South Boulevard in San Diego, California. Established in 2009, PRISM is dedicated to developing innovative treatments for important human diseases such as cancer and pulmonary fibrosis. Through the use of systems science principles, PRISM aims to improve patient care by discovering more effective and less toxic therapeutic solutions. At PRISM, scientists have created an integrated proteomic and imaging discovery platform to identify tissue-specific delivery targets for therapeutic agents, particularly in solid tumors. The institute's cutting-edge facilities in La Jolla, CA, combine advanced technologies in proteomics, in vivo imaging, and pre-clinical disease models to discover and validate novel therapeutic targets. PRISM is committed to improving the lives of patients by enhancing therapeutic potency and addressing critical unmet medical needs.

The UCSF Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program, located at 400 Parnassus Avenue in San Francisco, California, is a renowned institution dedicated to providing advanced treatment options with care and compassion for patients with blood disorders and cancers. Patients from around the world seek treatment from our specialized providers, who offer innovative therapies and the opportunity to participate in cutting-edge clinical trials, including CAR T-cell therapy. As part of the UCSF Helen Diller Family Comprehensive Cancer Center, our program offers a wide range of services to support cancer patients, including support groups, exercise classes, psychosocial support, and symptom management. Our research teams are at the forefront of cell-based immunotherapy for cancer, with a focus on developing breakthrough treatments for various blood cancers and solid tumors.

Dr. Hyunseok Kang is a medical oncologist and specialized cancer researcher located at 1600 Divisadero Street in San Francisco, California. Dr. Kang, also known as Hyu, specializes in treating adults with head and neck cancers using conventional chemotherapy, targeted therapy, and immunotherapy. He is actively involved in researching new therapies for head and neck cancers through clinical trials, focusing on improving the efficacy of immune checkpoint inhibitors and developing targeted approaches for rare cancers of the head and neck. Dr. Kang earned his medical degree at Yonsei University College of Medicine in Seoul, South Korea, and completed his residency and fellowship in internal medicine, hematology, and medical oncology in the United States. He is a fellow of the American College of Physicians and a member of several oncology and cancer research organizations. Prior to joining UCSF Health, Dr. Kang worked at the Johns Hopkins Hospital and served as an assistant professor of oncology at the Johns Hopkins University School of Medicine. He is currently involved in various research studies aimed at improving cancer treatment outcomes, including studies on adenoid cystic carcinoma, advanced solid tumors, and squamous cell carcinoma of the head and neck.

RefleXion Medical, located at 25841 Industrial Boulevard in Hayward, California, is a cutting-edge health institution that offers revolutionary SCINTIX® therapy for cancer treatment. This innovative therapy detects and responds to signals emitted from cancer cells themselves, delivering immediate treatment for tumors in the lung or bone, whether they arise from primary or metastatic disease. By introducing radiopharmaceuticals into the body, our machine creates a biological beacon that targets and treats solid tumors of any stage disease, even those in motion. This live targeting technology allows for precise treatment with potentially less impact on surrounding tissues. Many patients with stage four cancer are not typically candidates for definitive radiotherapy, but our SCINTIX therapy provides a new option for those with lung or bone tumors. By combining PET-CT and radiotherapy, we are able to find and treat cancer using emissions created by tumors themselves. This personalized approach to cancer treatment can be combined with chemotherapy, immunotherapy, and targeted drugs to potentially improve outcomes for patients.

Dr. Rahul Aggarwal, MD is a renowned developmental therapeutics specialist, genitourinary oncologist, and cancer researcher located at 1825 4th Street, San Francisco, California, United States. He is affiliated with the UCSF Helen Diller Family Comprehensive Cancer Center and serves as the director of the UCSF STAND Clinic, providing comprehensive care to men undergoing hormone therapy for prostate cancer. Dr. Aggarwal specializes in enrolling patients in early-phase clinical trials for advanced solid tumor malignancies, focusing on hormonal treatment strategies and molecular imaging techniques. He is a recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award and is a member of the American Society of Clinical Oncology. Dr. Aggarwal is dedicated to advancing cancer research and providing cutting-edge care to his patients. Visit Dr. Rahul Aggarwal, MD for expert treatment and compassionate care in the field of oncology.

Dr. Adil Daud, MD is an institution located at 1600 Divisadero Street, San Francisco, California, United States. This institution is a doctor specializing in oncology and melanoma, with a focus on immunotherapy research. Dr. Daud is also a history and literature buff. He is the co-director of the Melanoma Center and conducts research to better understand melanoma biology and develop new treatments. Dr. Daud has led numerous clinical trials expanding the use of gene therapy for melanoma. He has received awards such as the Young Investigator Award from the American Society of Clinical Oncology and has been recognized as a Castle Connolly Top Doctor. The institution is conducting studies on advanced melanoma and other solid tumors, as well as investigating the genes predictive of response to anti-PD-1 therapy in melanoma. Dr. Daud and his team at UCSF Health are dedicated to advancing treatments for advanced skin cancer and working towards a malaria-free world through partnerships and innovative healthcare solutions. For the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Dr. Katy K. Tsai, MD is a medical oncologist located at 1600 Divisadero Street in San Francisco, California. Specializing in treating melanoma and other skin cancers, Dr. Tsai also conducts clinical trials with her colleagues in cutaneous oncology to find new and improved therapies for patients with advanced melanoma or head and neck cancers. With a background in comparative literature from Brown University and a medical degree from Brown as well, Dr. Tsai has a passion for researching quality of life and outcomes for patients undergoing immunotherapy. She is a member of the American Society of Clinical Oncology and was born in Taiwan and raised in Toronto. Dr. Tsai is currently involved in several clinical trials focusing on advanced solid tumors and melanoma treatment. At UCSF Health, Dr. Tsai and her team are dedicated to working towards a malaria-free world through partnerships with various organizations and innovative healthcare solutions. For the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Dr. Pamela Munster, MD is a medical oncologist and the co-director of the Center for BRCA Research located in San Francisco, California, United States. She is currently conducting research on the effect of Denosumab in preventing breast cancer in women with a BRCA1 germline mutation. The institution also focuses on studying combination therapy in cancers with mutations in DNA repair genes and evaluating the efficacy and safety of various treatments for advanced solid tumors. Additionally, Dr. Munster and her team are involved in a study of Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient tumors. The institution is dedicated to advancing cancer research and providing the best possible care for patients. Please note that for the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Steven Corsello is a doctor and health institution located at 300 Pasteur Drive in Stanford, California, United States. The institution focuses on healing patients through a combination of science and compassion. The team at Stanford stimulates neurons to induce particular perceptions in mice's minds, and the institution is led by Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology. Dr. Corsello is a physician scientist and medical oncologist at Stanford University, with a laboratory that operates at the intersection of functional genomics and chemical biology. The goal of the institution is to advance novel molecular mechanisms of cancer inhibition to clinical use by leveraging phenotypic screening, developing new targeted therapy approaches against solid tumors, and building a comprehensive community resource for drug repurposing discovery.

Anurag K. Agrawal, MD is a world-class pediatric hematologist-oncologist and bone marrow transplant specialist located at 747 52nd Street in Oakland, California. Dr. Agrawal and his team at UCSF Benioff Children's Hospital Oakland provide extraordinary care for children and young adults with blood disorders and solid tumors. Dr. Agrawal is dedicated to providing stress-free visits for patients and their families, offering accommodations, admission, discharge, and procedure preparation services. He is passionate about integrative oncology, supportive care, health disparities, and global health, and has developed innovative programs that include complementary therapies like massage, acupuncture, and virtual reality.

Dr. David Oh, MD, PhD is a medical oncologist located at 1825 4th Street in San Francisco, California, United States. He specializes in caring for patients undergoing novel immunotherapies for cancer treatment, particularly focusing on prostate and bladder cancers. Dr. Oh conducts research to enhance cancer immunotherapies and leads clinical trials to evaluate new treatments for solid tumors. He is a member of various prestigious medical associations and has received awards for his contributions to oncology research. Additionally, UCSF Health, where Dr. Oh practices, is dedicated to advancing healthcare innovations to combat diseases like malaria through partnerships with global organizations. For the best browsing experience, it is recommended to use Chrome or Firefox instead of Internet Explorer.

Dr. Bogdan Eftimie, MD is a hematologist-oncologist located at 2500 Mowry Avenue in Fremont, California. He specializes in treating a variety of solid tumors and blood cancers, as well as noncancerous blood conditions. Dr. Eftimie is dedicated to building strong relationships with his patients, providing individualized care and promoting open communication. As the medical director of UCSF and Washington Hospital Healthcare System's joint medical oncology service, Dr. Eftimie works closely with a multidisciplinary team to offer comprehensive cancer care in southern Alameda County. Patients benefit from having their cases reviewed by experts at UCSF, while receiving treatment close to home.

Anurag K. Agrawal, MD is a world-class institution located at 2401 Shadelands Drive, Walnut Creek, California, United States. Specializing in pediatric hematology-oncology and bone marrow transplants, Dr. Agrawal and his team provide extraordinary care for children and young adults with blood disorders and solid tumors. With a focus on integrative oncology, supportive care, and global health, they offer stress-free visits and accommodations for patients and families. Dr. Agrawal is a pioneer in early-phase and cellular therapies, including CAR-T therapy, and is dedicated to addressing health disparities and access to care for underrepresented populations. His research projects aim to improve outcomes and quality of life for all patients. With a background in pediatrics from UCSF Benioff Children's Hospital Oakland, Dr. Agrawal is committed to providing the best possible care for his patients.

Dr. Caroline Hastings, MD is a world-class hematologist-oncologist and neuro-oncologist located at 2401 Shadelands Drive in Walnut Creek, California. She specializes in caring for children with blood diseases, including blood cancers, brain and spinal cord tumors, acute leukemias, and solid tumors. Dr. Hastings also has expertise in sickle cell disease, immune thrombocytopenic purpura, and lysosomal storage disorders in adults. In addition to providing exceptional care to her patients, Dr. Hastings is actively involved in research on rare diseases such as relapsed leukemia, brain tumors, and Niemann-Pick Type C disease. She is dedicated to finding new treatments through clinical trials and serves on advisory boards for foundations supporting those affected by these conditions.

Amol Rao, MD is a medical institution located at 18111 Brookhurst Street in Fountain Valley, California, United States. Dr. Rao serves as the Medical Director of Infusion Services at Saddleback Medical Center. Originally from Fremont in the Bay Area, Dr. Rao completed his medical degree at St. George’s University in 2007 and his specialty training in Hematology and Oncology at the University of Southern California/Norris Comprehensive Cancer Center in Los Angeles. He is triple board certified in Internal Medicine, Hematology, and Oncology, and treats adults with various types of solid tumors, malignant hematologic conditions, and benign blood disorders. Dr. Rao has a wide range of clinical experience and research interests, particularly in genitourinary malignancies. In addition to his medical work, he enjoys traveling, biking, and scuba diving. Dr. Rao conducts his practice at Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center. For more information or assistance, please call 877-696-3622.

Jack Freimann is a renowned doctor specializing in internal medicine, medical oncology, and hematology, located at 1801 West Romneya Drive in Anaheim, California. With 19 years of experience, Dr. Freimann is dedicated to providing top-quality care to his patients in Whittier and surrounding areas. He is actively involved in hospital leadership, serving on committees and as a past Chairman of the Departments of Medicine at Presbyterian Intercommunity Hospital and Whittier Hospital Medical Center. Dr. Freimann is triple-board-certified and received his medical degree from UCLA, followed by fellowship training at MD Anderson Cancer Center in Houston. He has presented papers at prestigious conferences and published articles in leading medical journals. Specializing in solid tumors and hematologic disorders, his interests lie in breast, colorectal, lung, prostate cancer, and lymphoma treatment.

Gurpreet Multani, MD is a medical institution located at 24411 Health Center Drive in Laguna Hills, California, United States. Dr. Multani, originally from Long Island, New York, is a triple board-certified doctor in Internal Medicine, Hematology, and Medical Oncology. He treats adults with solid tumors, malignant and benign hematologic disorders. Dr. Multani completed his medical degree at Drexel University in Philadelphia, Pennsylvania and his residency and fellowship at North Shore University Hospital in Manhasset, NY. He has been in private practice since 2010 and is currently a clinical instructor at Midwestern University College of Osteopathic Medicine. In addition to his medical practice, Dr. Multani enjoys spending time with his family, traveling, photography, hiking, and snowboarding. For more information or assistance, please call 877-696-3622.

Amol Rao, MD is a prestigious institution located at 24411 Health Center Drive in Laguna Hills, California, United States. Dr. Rao serves as the Medical Director of Infusion Services at Saddleback Medical Center. He is triple board certified in Internal Medicine, Hematology, and Oncology, specializing in treating adults with solid tumors, malignant hematologic conditions, and benign blood disorders. With extensive clinical experience in various settings, Dr. Rao has also conducted research in immunotherapy and published work in the field. His research interests include genitourinary malignancies such as kidney, bladder, and prostate cancers. Outside of his medical practice, Dr. Rao enjoys traveling, biking, and scuba diving. Services provided by Dr. Rao and his team can be accessed at Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center. For personalized assistance, please contact 877-696-3622.

Jacqueline Malekirad, MD is a doctor specializing in internal medicine, hematology, and oncology located at 24411 Health Center Drive in Laguna Hills, California. Dr. Malekirad received her medical education at the University of Washington School of Medicine and completed her residency at Greenwich Hospital Yale New Haven Health. She also completed a fellowship in Hematology/Oncology at Scripps Clinics in San Diego. Dr. Malekirad is passionate about treating all forms of blood disorders and solid tumor malignancies, with a specific interest in various types of cancer. She believes in empowering her patients by providing them with knowledge about their diseases so they can make informed decisions about their treatment. Dr. Malekirad is fluent in Farsi and enjoys spending time with her family and friends, traveling, listening to music, and cooking in her free time.

Jack Freimann is a renowned doctor specializing in internal medicine, medical oncology, and hematology, located at 900 South Main Street in Corona, California. With 19 years of experience, Dr. Freimann is dedicated to providing top-quality care to his patients in Whittier and surrounding areas. He is actively involved in hospital leadership, serving on committees and as Chairman of the Cancer Committee at Presbyterian Intercommunity Hospital. Dr. Freimann received his medical degree from UCLA and completed his fellowship training at MD Anderson Cancer Center in Houston. He has presented papers at prestigious medical conferences and published articles in leading medical journals. His expertise lies in treating a wide range of solid tumors and hematologic disorders, with a focus on breast cancer, colorectal cancer, lung cancer, prostate cancer, and lymphoma.

City of Hope Upland is an outpatient department of City of Hope National Medical Center, offering unparalleled cancer care in a healing environment at the foot of the San Gabriel Mountains in Upland, California. Our dedicated team of doctors and nurse practitioners specialize in medical oncology and hematology, providing consultations for all types of cancers. The facility features a comfortable infusion room with heated chairs and blankets, a nutrition center, and complimentary iPads and Wi-Fi for patients' convenience. City of Hope Upland offers advanced treatments for solid tumors, blood cancers, pediatric cancers, and a variety of surgical procedures, including robotic and HIPEC cytoreductive surgery. Our radiation oncology program is accredited by ASTRO, and our experts provide personalized treatment plans using the latest therapies. Patients have access to groundbreaking clinical trials and on-site urgent care and laboratory services. City of Hope Upland contracts with various insurance companies and ensures patients are protected from surprise medical bills. Our team of experienced physicians, including Dr. Naveen Gupta, Dr. Mark Hanna, Dr. Mehdi M. Kebria, and others, are committed to providing compassionate care and innovative treatments for all patients.

James Mason, MD is a renowned hematologist and oncologist located at 326 Santa Fe Drive, Encinitas, California, United States. With over 26 years of experience, Dr. Mason specializes in blood and bone marrow transplantation. He works collaboratively with a team of physicians, nurses, pharmacists, and specialists to provide exceptional patient care. Dr. Mason's expertise includes therapy programs for breast cancer, solid tumors, Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma, acute and chronic leukemia, and other blood and bone marrow diseases. He is also actively involved in research on acute leukemias and computational biology. As the director of the Scripps Blood and Marrow Transplant (BMT) Program and the stem cell lab at Scripps Clinic Torrey Pines, Dr. Mason offers innovative care through dose-intensive chemotherapy and immunotherapy. The BMT Program is recognized as a leader in the field on the West Coast. Dr. Mason is currently accepting new patients, and depending on your insurance, a referral may be required. Contact James Mason, MD for expert care in hematology and oncology.